Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-07-09
1988-11-29
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 62, 546 70, A61K 31435, C07D47114, C07D491147, C07D49514
Patent
active
047882026
ABSTRACT:
The invention concerns sulphonamides of general formula ##STR1## and their pharmaceutically acceptable acid addition salts. In formula (I), R represents hydrogen or lower alkyl, R.sup.1 and R.sup.2 which may be the same or different each represents hydrogen, lower alkyl, lower alkoxy or halogen, R.sup.3 and R.sup.4 which may be the same or different each represents lower alkyl, halo(lower)alkyl or aryl, A represents a lower alkylene group having 1 to 3 carbon atoms in the chain between the two N atoms and X represents O, S or NR.sup.5 (where R.sup.5 is hydrogen or lower alkyl). The compounds possess .alpha..sub.2 -adrenoceptor antagonistic activity in warm blooded animals.
REFERENCES:
patent: 4640924 (1987-02-01), White et al.
patent: 4686226 (1987-08-01), Huff et al.
patent: 4690928 (1987-09-01), Huff et al.
Daus Donald G.
John Wyeth & Brother Limited
Tarnowski George
Teoli, Jr. William A.
LandOfFree
Sulphonamide derivatives as .alpha..sub.2 -adrenoceptor antagoni does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulphonamide derivatives as .alpha..sub.2 -adrenoceptor antagoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulphonamide derivatives as .alpha..sub.2 -adrenoceptor antagoni will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363750